Expressing support for the protection of Medicare part D's six protected classes.
USA117th CongressHRES-1390| House
| Updated: 9/23/2022
Grace F. Napolitano
Democratic Representative
California
Cosponsors (22)
John Katko (Republican)Barbara Lee (Democratic)Mikie Sherrill (Democratic)Raúl M. Grijalva (Democratic)David J. Trone (Democratic)Darren Soto (Democratic)Pete Aguilar (Democratic)Tony Cárdenas (Democratic)Paul Tonko (Democratic)Lucille Roybal-Allard (Democratic)Ann M. Kuster (Democratic)André Carson (Democratic)Doris O. Matsui (Democratic)Raja Krishnamoorthi (Democratic)Betty McCollum (Democratic)James P. McGovern (Democratic)Nydia M. Velázquez (Democratic)Albio Sires (Democratic)Brian K. Fitzpatrick (Republican)Jenniffer González-Colón (Republican)Grace Meng (Democratic)Bill Pascrell (Democratic)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
This resolution expresses support for the six protected classes of prescription drugs under the Medicare prescription drug benefit: antidepressants, antipsychotics, anticonvulsants, immunosuppressants, antiretrovirals, and antineoplastics.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Health
Expressing support for the protection of Medicare part D's six protected classes.
USA117th CongressHRES-1390| House
| Updated: 9/23/2022
This resolution expresses support for the six protected classes of prescription drugs under the Medicare prescription drug benefit: antidepressants, antipsychotics, anticonvulsants, immunosuppressants, antiretrovirals, and antineoplastics.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Grace F. Napolitano
Democratic Representative
California
Cosponsors (22)
John Katko (Republican)Barbara Lee (Democratic)Mikie Sherrill (Democratic)Raúl M. Grijalva (Democratic)David J. Trone (Democratic)Darren Soto (Democratic)Pete Aguilar (Democratic)Tony Cárdenas (Democratic)Paul Tonko (Democratic)Lucille Roybal-Allard (Democratic)Ann M. Kuster (Democratic)André Carson (Democratic)Doris O. Matsui (Democratic)Raja Krishnamoorthi (Democratic)Betty McCollum (Democratic)James P. McGovern (Democratic)Nydia M. Velázquez (Democratic)Albio Sires (Democratic)Brian K. Fitzpatrick (Republican)Jenniffer González-Colón (Republican)Grace Meng (Democratic)Bill Pascrell (Democratic)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted